Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001883986-25-000009

Chief Legal Officer sold 33,807 shares at $14.75 ($498,653)

  • Chief Legal Officer acquired 33,807 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara Chief Legal Officer 2025-09-29 Option exercise 10b5-1 +33,807 $9.24 $312,495 33,807 D
Meisner Lara Chief Legal Officer 2025-09-29 Sale 10b5-1 −33,807 $14.75 $498,653 0 D
Derivatives
Meisner Lara Chief Legal Officer 2025-09-29 Option exercise · Stock Option (Right to Buy) 10b5-1 −33,807 101,423 D
Open-market sales · 33,807 sh · avg $14.75 · $498,653
Loading xslF345X05/wk-form4_1759352250.xml…